/NUZ
NUZ
Updated 8 Oct 08:01 am
$0.09
NEURIZON THERAPEUTICS LIMITED
1D+3.45%
1M+45.16%
1Y-35.71%
Track your position in NUZ
Sign in to TradeLedgr to record trades in NUZ (NEURIZON THERAPEUTICS LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
06 Oct 2026 11:04 PM
Updated Investor Presentation and Webinar Reminder11882KB
Company Presentation
05 Oct 2026 10:57 PM
FDA Type C Feedback, HEALEY trial potentially registrational320KB
Progress Report
30 Sep 2026 11:30 PM
Dr Chris Bremer commences as Neurizon CEO449KB
Web Cast
17 Sep 2026 3:59 AM
Change of Director's Interest Notice116KB
Change of Director's Interest Notice
15 Sep 2026 8:17 AM
Notification of cessation of securities - NUZ9KB
Appendix 3H (Notification of cessation of securities)
Fundamentals
P/E Ratio
—
Div Yield
0.00%
EPS
$-0.0181
Avg Vol
—
52W High
$0.150
52W Low
$0.053
Company Profile
To develop its own drug discovery intellectual property for the treatment of different types of neurological diseases
Financial History
2026A
$-10.7M profit
$0.0M rev
2025A
$-16.6M profit
$0.0M rev
2024A
$-7.7M profit
$0.0M rev